ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

ImmuneOncia Therapeutics Statistics

Total Valuation

KOSDAQ:424870 has a market cap or net worth of KRW 645.98 billion. The enterprise value is 622.61 billion.

Market Cap	645.98B
Enterprise Value	622.61B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:424870 has 74.17 million shares outstanding. The number of shares has increased by 24.61% in one year.

Current Share Class	74.17M
Shares Outstanding	74.17M
Shares Change (YoY)	+24.61%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	n/a
Float	20.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5,808.70
PB Ratio	22.73
P/TBV Ratio	27.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-22.75
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-26.95

Financial Position

The company has a current ratio of 6.22, with a Debt / Equity ratio of 0.00.

Current Ratio	6.22
Quick Ratio	5.53
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-5,465.39

Financial Efficiency

Return on equity (ROE) is -114.40% and return on invested capital (ROIC) is -72.92%.

Return on Equity (ROE)	-114.40%
Return on Assets (ROA)	-58.99%
Return on Invested Capital (ROIC)	-72.92%
Return on Capital Employed (ROCE)	-96.95%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	9,711.00
200-Day Moving Average	7,602.65
Relative Strength Index (RSI)	49.62
Average Volume (20 Days)	547,035

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:424870 had revenue of KRW 111.21 million and -27.36 billion in losses. Loss per share was -390.00.

Revenue	111.21M
Gross Profit	98.26M
Operating Income	-28.00B
Pretax Income	-27.36B
Net Income	-27.36B
EBITDA	-27.11B
EBIT	-28.00B
Loss Per Share	-390.00

Balance Sheet

The company has 23.44 billion in cash and 69.53 million in debt, with a net cash position of 23.37 billion or 315.08 per share.

Cash & Cash Equivalents	23.44B
Total Debt	69.53M
Net Cash	23.37B
Net Cash Per Share	315.08
Equity (Book Value)	28.42B
Book Value Per Share	384.21
Working Capital	22.25B

Cash Flow

In the last 12 months, operating cash flow was -22.78 billion and capital expenditures -329.97 million, giving a free cash flow of -23.11 billion.

Operating Cash Flow	-22.78B
Capital Expenditures	-329.97M
Depreciation & Amortization	890.41M
Net Borrowing	-51.87M
Free Cash Flow	-23.11B
FCF Per Share	-311.54

Margins

Gross Margin	88.36%
Operating Margin	-25,182.04%
Pretax Margin	-24,605.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:424870 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.61%
Shareholder Yield	-24.61%
Earnings Yield	-4.24%
FCF Yield	-3.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:424870 has an Altman Z-Score of 56.14 and a Piotroski F-Score of 2.

Altman Z-Score	56.14
Piotroski F-Score	2